These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4439298)

  • 1. [Expediency of using beta-adrenoblockaders for normalization of the function of a thyrotoxic heart].
    Smolenskiĭ VS; Abinder AA; Romm-Bugoslavskaia ES; Levchenko TP; Kitrov NK
    Ter Arkh; 1974; 46(9):130-5. PubMed ID: 4439298
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of cardiac glycosides on hemodynamics and inotropism of the thyrotoxic heart].
    Abinder AA; Smolenskiĭ VS; Rom-Bugoslavskaia ES
    Ter Arkh; 1974; 46(10):93-9. PubMed ID: 4432230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the effect of propranolol on heart mechanics and contractility in experimentally induced hyperthyroidism].
    Strauer BE; Scherpe A
    Verh Dtsch Ges Kreislaufforsch; 1972; 38():262-8. PubMed ID: 4663552
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy in the use of beta-adrenergic blockaders in the treatment of thyrotoxic disorders of the heart].
    Smolenskiĭ VS; Rom-Boguslavskaia ES; Abinder AA; Levchenko TP
    Probl Endokrinol (Mosk); 1973; 19(6):20-5. PubMed ID: 4148862
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute effects of beta receptor blockaders in hyperthyroidism].
    Váradi A; Földes J; Gyertyánffy G; Borvendég J; Brüll J
    Orv Hetil; 1981 May; 122(18):1069-72. PubMed ID: 6115351
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial contractility, and the effects of beta-adrenergic blockade in hypothyroidism and hyperthyroidism.
    Howitt G; Rowlands DJ; Leung DY; Logan WF
    Clin Sci; 1968 Jun; 34(3):485-95. PubMed ID: 5662591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of propranolol on electrophysiologic features of the heart in patients with hyperthyroidism].
    Gasińska T; Prochaczek F; Izbicka M
    Endokrynol Pol; 1991; 42(4):533-42. PubMed ID: 1364504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adrenergic beta blockaders in hyperthyroidism (adrenergic beta block with propranolol as the sole preparatory treatment of hyperthyroidism in parital thyroidectomy].
    Ramírez Del Villar E; Wurst Zevallos G; Bouroncle Carreón M; Uribe LJ
    Rev Neuropsiquiatr; 1973 Jun; 36(2):107-16. PubMed ID: 4793306
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta adrenergic blockade with propranolol in conscious euthyroid and thyrotoxic calves: dosage requirements and effects on heart rate and left ventricular performance.
    Goldman S; Olajos M; Pieniaszek H; Perrier D; Mayersohn M; Morkin E
    J Pharmacol Exp Ther; 1981 Nov; 219(2):394-9. PubMed ID: 7288628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of inderal on the heart of thyrotoxicosis patients (a clinico-roentgenologic study)].
    Astapov BM; Bogoliubov VM; Matveenko EG; Konstantinov IuN; Sorokina VG
    Klin Med (Mosk); 1972 Aug; 50(8):90-5. PubMed ID: 4660362
    [No Abstract]   [Full Text] [Related]  

  • 11. [Propranolol in the preoperative preparation of thyrotoxic patients].
    Kuang YL
    Zhonghua Wai Ke Za Zhi; 1984 Nov; 22(11):645-7, 699. PubMed ID: 6537314
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contractile function of the myocardium in thyrotoxicosis].
    Rom-Bugoslavskaia ES
    Patol Fiziol Eksp Ter; 1974; (6):20-5. PubMed ID: 4444837
    [No Abstract]   [Full Text] [Related]  

  • 13. [Roentgenometric evaluation of biomechanics of the thyrotoxic heart].
    Gorbushin NG; Matveenko EG; Konstantinov IuN
    Klin Med (Mosk); 1976 Sep; 54(9):118-22. PubMed ID: 1003906
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic changes of the heart in hyperthyroidism].
    Triandaf I; Ungureanu G; Pencea V; Gneazdovschi V
    Stud Cercet Endocrinol; 1973; 24(3):203-9. PubMed ID: 4703919
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta blocking agent: Propranolol].
    Ikezono E; Yasuda K; Kumazawa M; Sawa T; Aono M
    Masui; 1969 Sep; 18(9):793-807. PubMed ID: 4900621
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of prednisolone on the vascular tonicity of patients with thyrotoxicosis].
    Dimova MN
    Probl Endokrinol (Mosk); 1975; 21(3):32-6. PubMed ID: 1144320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The beta-blocking drugs in hyperthyroidism. 3. Effects on the post-thyroidectomy course and on the thyrotoxic crisis].
    Giardina F; Bellotti G; De Gregori ME; Ghidini O
    Minerva Med; 1971 Mar; 62(26):1383-92. PubMed ID: 5108134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-receptor blocking agents in the preparation for surgery in hyperthyroidism].
    Dichtl K; Bergmann H
    Wien Med Wochenschr; 1969 Jun; 119(25):476-80. PubMed ID: 5802407
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional cardiac reserve in thyrotoxicosis and its plastic ensurance.
    Golber LM; Kandror VI
    Cor Vasa; 1969; 11(1):35-47. PubMed ID: 5789825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.